APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Indoleamine 2,3 Dioxygenase 1

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Indoleamine 2,3 Dioxygenase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174002450319 December 2025191 pages

Choose your research edition.

Industry ResearchIndoleamine 2,3 Dioxygenase 1 Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Indoleamine 2,3 Dioxygenase 1 Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Indoleamine 2,3 Dioxygenase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Indoleamine 2,3 Dioxygenase 1 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Indoleamine 2,3 Dioxygenase 1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Indoleamine 2,3 Dioxygenase 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Indoleamine 2,3 Dioxygenase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Indoleamine 2,3 Dioxygenase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Indoleamine 2,3 Dioxygenase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Indoleamine 2,3 Dioxygenase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Indoleamine 2,3 Dioxygenase 1 include F. Hoffmann-La Roche Ltd, Pfizer Inc, Bristol-Myers Squibb Company, Regen BioPharma Inc, Redx Pharma Plc, NewLink Genetics Corp, Netherlands Translational Research Center BV, Kyowa Hakko Kirin and IO Biotech ApS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Indoleamine 2,3 Dioxygenase 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Indoleamine 2,3 Dioxygenase 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Indoleamine 2,3 Dioxygenase 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Indoleamine 2,3 Dioxygenase 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Indoleamine 2,3 Dioxygenase 1 Segment by Company

F. Hoffmann-La Roche Ltd

Pfizer Inc

Bristol-Myers Squibb Company

Regen BioPharma Inc

Redx Pharma Plc

NewLink Genetics Corp

Netherlands Translational Research Center BV

Kyowa Hakko Kirin

IO Biotech ApS

Incyte Corp

Globavir Biosciences Inc

Genentech Inc

Ensemble Therapeutics Corp

BirchBioMed Inc

Indoleamine 2,3 Dioxygenase 1 Segment by Type

BMS-986205

Dcellvax

F-001287

Galanal

Epacadostat

Others

Indoleamine 2,3 Dioxygenase 1 Segment by Application

Gastric Cancer

Aolpecia

Glioma

Cervical Cancer

Others

Indoleamine 2,3 Dioxygenase 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indoleamine 2,3 Dioxygenase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Indoleamine 2,3 Dioxygenase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indoleamine 2,3 Dioxygenase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Indoleamine 2,3 Dioxygenase 1 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Indoleamine 2,3 Dioxygenase 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Indoleamine 2,3 Dioxygenase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Indoleamine 2,3 Dioxygenase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Indoleamine 2,3 Dioxygenase 1 Industry Trends Table 2. Indoleamine 2,3 Dioxygenase 1 Industry Drivers Table 3. Indoleamine 2,3 Dioxygenase 1 Industry Opportunities and Challenges Table 4. Indoleamine 2,3 Dioxygenase 1 Industry Restraints Table 5. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Indoleamine 2,3 Dioxygenase 1 Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Manufacturers Table 9. Global Indoleamine 2,3 Dioxygenase 1 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Indoleamine 2,3 Dioxygenase 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Indoleamine 2,3 Dioxygenase 1 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Indoleamine 2,3 Dioxygenase 1 Manufacturers, Product Type & Application Table 13. Global Indoleamine 2,3 Dioxygenase 1 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Indoleamine 2,3 Dioxygenase 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of BMS-986205 Table 17. Major Manufacturers of Dcellvax Table 18. Major Manufacturers of F-001287 Table 19. Major Manufacturers of Galanal Table 20. Major Manufacturers of Epacadostat Table 21. Major Manufacturers of Others Table 22. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 24. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2027-2032) & (K Units) Table 25. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2021-2026) Table 26. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2027-2032) Table 27. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2026) & (K Units) Table 29. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2027-2032) & (K Units) Table 30. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Type (2021-2026) Table 31. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Gastric Cancer Table 33. Major Manufacturers of Aolpecia Table 34. Major Manufacturers of Glioma Table 35. Major Manufacturers of Cervical Cancer Table 36. Major Manufacturers of Others Table 37. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 39. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2027-2032) & (K Units) Table 40. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2021-2026) Table 41. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2027-2032) Table 42. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 43. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2026) & (K Units) Table 44. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2027-2032) & (K Units) Table 45. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Application (2021-2026) Table 46. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Application (2027-2032) Table 47. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2021-2026) & (K Units) Table 49. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Region (2021-2026) Table 50. Global Indoleamine 2,3 Dioxygenase 1 Sales Forecasted by Region (2027-2032) & (K Units) Table 51. Global Indoleamine 2,3 Dioxygenase 1 Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 54. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2027-2032) & (K Units) Table 55. Europe Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 57. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2027-2032) & (K Units) Table 58. Asia Pacific Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Asia Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 60. Asia Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Country (2027-2032) & (K Units) Table 61. South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 63. South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country (2027-2032) & (K Units) Table 64. Global Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region (2021-2026) Table 68. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region (2027-2032) Table 69. F. Hoffmann-La Roche Ltd Company Information Table 70. F. Hoffmann-La Roche Ltd Business Overview Table 71. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 73. F. Hoffmann-La Roche Ltd Recent Development Table 74. Pfizer Inc Company Information Table 75. Pfizer Inc Business Overview Table 76. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 78. Pfizer Inc Recent Development Table 79. Bristol-Myers Squibb Company Company Information Table 80. Bristol-Myers Squibb Company Business Overview Table 81. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 83. Bristol-Myers Squibb Company Recent Development Table 84. Regen BioPharma Inc Company Information Table 85. Regen BioPharma Inc Business Overview Table 86. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 88. Regen BioPharma Inc Recent Development Table 89. Redx Pharma Plc Company Information Table 90. Redx Pharma Plc Business Overview Table 91. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 93. Redx Pharma Plc Recent Development Table 94. NewLink Genetics Corp Company Information Table 95. NewLink Genetics Corp Business Overview Table 96. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 98. NewLink Genetics Corp Recent Development Table 99. Netherlands Translational Research Center BV Company Information Table 100. Netherlands Translational Research Center BV Business Overview Table 101. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 103. Netherlands Translational Research Center BV Recent Development Table 104. Kyowa Hakko Kirin Company Information Table 105. Kyowa Hakko Kirin Business Overview Table 106. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 108. Kyowa Hakko Kirin Recent Development Table 109. IO Biotech ApS Company Information Table 110. IO Biotech ApS Business Overview Table 111. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 113. IO Biotech ApS Recent Development Table 114. Incyte Corp Company Information Table 115. Incyte Corp Business Overview Table 116. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 118. Incyte Corp Recent Development Table 119. Globavir Biosciences Inc Company Information Table 120. Globavir Biosciences Inc Business Overview Table 121. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 123. Globavir Biosciences Inc Recent Development Table 124. Genentech Inc Company Information Table 125. Genentech Inc Business Overview Table 126. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 128. Genentech Inc Recent Development Table 129. Ensemble Therapeutics Corp Company Information Table 130. Ensemble Therapeutics Corp Business Overview Table 131. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 133. Ensemble Therapeutics Corp Recent Development Table 134. BirchBioMed Inc Company Information Table 135. BirchBioMed Inc Business Overview Table 136. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 138. BirchBioMed Inc Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Indoleamine 2,3 Dioxygenase 1 Distributors List Table 142. Indoleamine 2,3 Dioxygenase 1 Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Indoleamine 2,3 Dioxygenase 1 Product Image Figure 2. Global Indoleamine 2,3 Dioxygenase 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Indoleamine 2,3 Dioxygenase 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Indoleamine 2,3 Dioxygenase 1 Sales (2021-2032) & (K Units) Figure 5. Global Indoleamine 2,3 Dioxygenase 1 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Indoleamine 2,3 Dioxygenase 1 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. BMS-986205 Image Figure 9. Dcellvax Image Figure 10. F-001287 Image Figure 11. Galanal Image Figure 12. Epacadostat Image Figure 13. Others Image Figure 14. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2021-2032) Figure 17. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Type (2021-2032) Figure 20. Gastric Cancer Image Figure 21. Aolpecia Image Figure 22. Glioma Image Figure 23. Cervical Cancer Image Figure 24. Others Image Figure 25. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2021-2032) Figure 28. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 29. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Application (2021-2032) Figure 31. North America Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 32. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2021-2032) Figure 33. U.S. Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Canada Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Mexico Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2021-2032) Figure 38. Germany Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 39. France Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 40. U.K. Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Italy Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Netherlands Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2021-2032) Figure 45. China Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Japan Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Korea Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Southeast Asia Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 49. India Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Australia Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2021-2032) Figure 53. Brazil Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 54. South Africa Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Saudi Arabia Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Turkey Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Argentina Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 58. UAE Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Egypt Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Chile Indoleamine 2,3 Dioxygenase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Global Indoleamine 2,3 Dioxygenase 1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Figure 64. North America Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Figure 66. Europe Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Indoleamine 2,3 Dioxygenase 1 Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Indoleamine 2,3 Dioxygenase 1 Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • BMS-986205
  • Dcellvax
  • F-001287
  • Galanal
  • Epacadostat
  • Others
Applications
  • Gastric Cancer
  • Aolpecia
  • Glioma
  • Cervical Cancer
  • Others
Companies covered
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Regen BioPharma Inc
  • Redx Pharma Plc
  • NewLink Genetics Corp
  • Netherlands Translational Research Center BV
  • Kyowa Hakko Kirin
  • IO Biotech ApS
  • Incyte Corp
  • Globavir Biosciences Inc
  • Genentech Inc
  • Ensemble Therapeutics Corp
  • BirchBioMed Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Indoleamine 2,3 Dioxygenase 1 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Indoleamine 2,3 Dioxygenase 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Indoleamine 2,3 Dioxygenase 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Indoleamine 2,3 Dioxygenase 1 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Indoleamine 2,3 Dioxygenase 1 Market Dynamics
  1. 2.1 Indoleamine 2,3 Dioxygenase 1 Industry Trends
  2. 2.2 Indoleamine 2,3 Dioxygenase 1 Industry Drivers
  3. 2.3 Indoleamine 2,3 Dioxygenase 1 Industry Opportunities and Challenges
  4. 2.4 Indoleamine 2,3 Dioxygenase 1 Industry Restraints
3 Indoleamine 2,3 Dioxygenase 1 Market by Manufacturers
  1. 3.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Indoleamine 2,3 Dioxygenase 1 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Indoleamine 2,3 Dioxygenase 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Indoleamine 2,3 Dioxygenase 1 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Indoleamine 2,3 Dioxygenase 1 Manufacturers, Product Type & Application
  7. 3.7 Global Indoleamine 2,3 Dioxygenase 1 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Indoleamine 2,3 Dioxygenase 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Indoleamine 2,3 Dioxygenase 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Indoleamine 2,3 Dioxygenase 1 Tier 1, Tier 2, and Tier 3
4 Indoleamine 2,3 Dioxygenase 1 Market by Type
  1. 4.1 Indoleamine 2,3 Dioxygenase 1 Type Introduction
  2. 4.1.1 BMS-986205
  3. 4.1.2 Dcellvax
  4. 4.1.3 F-001287
  5. 4.1.4 Galanal
  6. 4.1.5 Epacadostat
  7. 4.1.6 Others
  8. 4.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Type
  9. 4.2.1 Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2032)
  11. 4.2.3 Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2021-2032)
  12. 4.3 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type
  13. 4.3.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2032)
  15. 4.3.3 Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Type (2021-2032)
5 Indoleamine 2,3 Dioxygenase 1 Market by Application
  1. 5.1 Indoleamine 2,3 Dioxygenase 1 Application Introduction
  2. 5.1.1 Gastric Cancer
  3. 5.1.2 Aolpecia
  4. 5.1.3 Glioma
  5. 5.1.4 Cervical Cancer
  6. 5.1.5 Others
  7. 5.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Application
  8. 5.2.1 Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2032)
  10. 5.2.3 Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2021-2032)
  11. 5.3 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application
  12. 5.3.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2032)
  14. 5.3.3 Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Application (2021-2032)
6 Global Indoleamine 2,3 Dioxygenase 1 Sales by Region
  1. 6.1 Global Indoleamine 2,3 Dioxygenase 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2021-2032)
  3. 6.2.1 Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2021-2026)
  4. 6.2.2 Global Indoleamine 2,3 Dioxygenase 1 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region
  1. 7.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region
  2. 7.1.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2021-2026)
  4. 7.1.3 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2027-2032)
  5. 7.1.4 Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032)
  8. 7.2.2 North America Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032)
  11. 7.3.2 Europe Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 F. Hoffmann-La Roche Ltd
  2. 8.1.1 F. Hoffmann-La Roche Ltd Company Information
  3. 8.1.2 F. Hoffmann-La Roche Ltd Business Overview
  4. 8.1.3 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  6. 8.1.5 F. Hoffmann-La Roche Ltd Recent Developments
  7. 8.2 Pfizer Inc
  8. 8.2.1 Pfizer Inc Company Information
  9. 8.2.2 Pfizer Inc Business Overview
  10. 8.2.3 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  12. 8.2.5 Pfizer Inc Recent Developments
  13. 8.3 Bristol-Myers Squibb Company
  14. 8.3.1 Bristol-Myers Squibb Company Company Information
  15. 8.3.2 Bristol-Myers Squibb Company Business Overview
  16. 8.3.3 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  18. 8.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 8.4 Regen BioPharma Inc
  20. 8.4.1 Regen BioPharma Inc Company Information
  21. 8.4.2 Regen BioPharma Inc Business Overview
  22. 8.4.3 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  24. 8.4.5 Regen BioPharma Inc Recent Developments
  25. 8.5 Redx Pharma Plc
  26. 8.5.1 Redx Pharma Plc Company Information
  27. 8.5.2 Redx Pharma Plc Business Overview
  28. 8.5.3 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  30. 8.5.5 Redx Pharma Plc Recent Developments
  31. 8.6 NewLink Genetics Corp
  32. 8.6.1 NewLink Genetics Corp Company Information
  33. 8.6.2 NewLink Genetics Corp Business Overview
  34. 8.6.3 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  36. 8.6.5 NewLink Genetics Corp Recent Developments
  37. 8.7 Netherlands Translational Research Center BV
  38. 8.7.1 Netherlands Translational Research Center BV Company Information
  39. 8.7.2 Netherlands Translational Research Center BV Business Overview
  40. 8.7.3 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  42. 8.7.5 Netherlands Translational Research Center BV Recent Developments
  43. 8.8 Kyowa Hakko Kirin
  44. 8.8.1 Kyowa Hakko Kirin Company Information
  45. 8.8.2 Kyowa Hakko Kirin Business Overview
  46. 8.8.3 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  48. 8.8.5 Kyowa Hakko Kirin Recent Developments
  49. 8.9 IO Biotech ApS
  50. 8.9.1 IO Biotech ApS Company Information
  51. 8.9.2 IO Biotech ApS Business Overview
  52. 8.9.3 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  54. 8.9.5 IO Biotech ApS Recent Developments
  55. 8.10 Incyte Corp
  56. 8.10.1 Incyte Corp Company Information
  57. 8.10.2 Incyte Corp Business Overview
  58. 8.10.3 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  60. 8.10.5 Incyte Corp Recent Developments
  61. 8.11 Globavir Biosciences Inc
  62. 8.11.1 Globavir Biosciences Inc Company Information
  63. 8.11.2 Globavir Biosciences Inc Business Overview
  64. 8.11.3 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  66. 8.11.5 Globavir Biosciences Inc Recent Developments
  67. 8.12 Genentech Inc
  68. 8.12.1 Genentech Inc Company Information
  69. 8.12.2 Genentech Inc Business Overview
  70. 8.12.3 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  72. 8.12.5 Genentech Inc Recent Developments
  73. 8.13 Ensemble Therapeutics Corp
  74. 8.13.1 Ensemble Therapeutics Corp Company Information
  75. 8.13.2 Ensemble Therapeutics Corp Business Overview
  76. 8.13.3 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  78. 8.13.5 Ensemble Therapeutics Corp Recent Developments
  79. 8.14 BirchBioMed Inc
  80. 8.14.1 BirchBioMed Inc Company Information
  81. 8.14.2 BirchBioMed Inc Business Overview
  82. 8.14.3 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  84. 8.14.5 BirchBioMed Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Indoleamine 2,3 Dioxygenase 1 Value Chain Analysis
  2. 9.1.1 Indoleamine 2,3 Dioxygenase 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Indoleamine 2,3 Dioxygenase 1 Production Mode & Process
  6. 9.2 Indoleamine 2,3 Dioxygenase 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Indoleamine 2,3 Dioxygenase 1 Distributors
  9. 9.2.3 Indoleamine 2,3 Dioxygenase 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst